A Prospective Phase II Study of Apatinib Plus Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

被引：0
|
作者：
Ma, K. [1 ]
Xu, Y. [1 ]
Cai, Y. [1 ]
Wang, X. [1 ]
Sun, C. [1 ]
Guo, Y. [1 ]
Qiu, S. [1 ]
机构：
[1] First Hosp Jilin Univ, Changchun, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
small-cell lung cancer; Apatinib; Phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP10.05
引用
收藏
页码：S216 / S217
页数：2
相关论文
共 50 条
  • [1] A phase II study of antiangiogenic therapy (Apatinib) plus chemotherapy as second-line treatment in advanced small cell lung cancer
    Xu, Yinghui
    Wang, Xu
    Sun, Chao
    Gao, Zhiru
    He, Hua
    Qiu, Shi
    Guo, Ye
    Ma, Xiaohui
    Song, Junya
    Ma, Kewei
    CANCER MEDICINE, 2023, 12 (03): : 2979 - 2989
  • [2] A Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed from Two or More Lines of Chemotherapy
    Liu, Y.
    Hu, X.
    Jiang, J.
    Zhou, S.
    Liu, P.
    Li, J.
    Wang, Y.
    Hao, X.
    Shi, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2287 - S2287
  • [3] A Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed from Two or More Lines of Chemotherapy
    Liu, Y.
    Hu, X.
    Zhou, S.
    Li, J.
    Liu, P.
    Wang, Y.
    Hao, X.
    Shi, Y.
    Jiang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S573 - S574
  • [4] Phase II study with docetaxel in pretreated patients with small cell lung cancer
    Samantas, E
    Kiamouris, C
    Kalofonos, H
    Kourousis, H
    Aravantinos, G
    Janinis, J
    Androulakis, N
    Kourmpanis, V
    Fountzilas, G
    Skarlos, D
    ANNALS OF ONCOLOGY, 1998, 9 : 104 - 104
  • [5] A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non-small-cell Lung Cancer
    Wu, Fengying
    Zhang, Shijia
    Xiong, Anwen
    Gao, Guanghui
    Li, Wei
    Cai, Weijing
    Su, Chunxia
    Chen, Xiaoxia
    Zhou, Fei
    Zhao, Jing
    Ren, Shengxiang
    Zhou, Caicun
    CLINICAL LUNG CANCER, 2018, 19 (06) : E831 - E842
  • [6] Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial
    Mengru Cao
    Hailing Lu
    Shi Yan
    Hui Pang
    Lichun Sun
    Chunhong Li
    Xuesong Chen
    Wei Liu
    Jing Hu
    Jian Huang
    Ying Xing
    Ningzhi Zhang
    Yingqi Chen
    Ting He
    Danni Zhao
    Yuanyuan Sun
    Lin Zhao
    Xiaomeng Liu
    Li Cai
    BMC Cancer, 23
  • [7] Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial
    Cao, Mengru
    Lu, Hailing
    Yan, Shi
    Pang, Hui
    Sun, Lichun
    Li, Chunhong
    Chen, Xuesong
    Liu, Wei
    Hu, Jing
    Huang, Jian
    Xing, Ying
    Zhang, Ningzhi
    Chen, Yingqi
    He, Ting
    Zhao, Danni
    Sun, Yuanyuan
    Zhao, Lin
    Liu, Xiaomeng
    Cai, Li
    BMC CANCER, 2023, 23 (01)
  • [8] A phase II study of VM-26 plus lonidamine in pretreated small cell lung cancer
    Gridelli, C
    DeMarinis, F
    Rossi, A
    Tucci, E
    Daprile, M
    Cioffi, R
    Cortesi, E
    Migliorino, R
    Pisano, A
    Scognamiglio, F
    DiGiacomo, R
    Bianco, AR
    ANTICANCER RESEARCH, 1997, 17 (2B) : 1277 - 1279
  • [9] Brachytherapy plus chemotherapy in advanced non small cell lung cancer (NSCLC) phase II trial
    Grigorescu, A
    Bacinschi, X
    Radoi, S
    Ciocaltei, V
    LUNG CANCER, 2005, 49 : S380 - S380
  • [10] Phase II study of plitidepsin in pretreated patients with localty advanced or metastatic non-small cell lung cancer
    Peschel, Christian
    Hartmann, Joerg T.
    Schmittet, Alexander
    Bokemeyer, Carsten
    Schneller, Folker
    Keilholz, Ulrich
    Buchheidt, Dieter
    Millan, Susana
    Izquierdo, Miguel Angel
    Hofheinz, Ralf-Dieter
    LUNG CANCER, 2008, 60 (03) : 374 - 380
12345